Embody
  • Get Started
  • Our Top Products
  • GLP-1 Science
  • What To Expect
  • Market Leading Cost
  • FAQ
  • Contact Us

Terms of Service

Last updated: September 8, 2026

These Terms of Service ("Terms") outline the rules and conditions governing your access to and use of the services offered by Embody, operating as Embody ("Embody," "we," "us," or "our"). By accessing or using our website, platform, or services, you acknowledge that you have read, understood, and agree to be bound by these Terms. If you do not agree, you may not use the services.

Eligibility

You must be at least 18 years of age, reside in the United States, and provide accurate, complete, and current information to use our services.

Scope of Services

Embody facilitates connections between patients, licensed healthcare providers, and licensed U.S. pharmacies for telehealth consultations and prescription fulfillment. The available visit format depends on the service, your location, and clinical requirements. A licensed clinician determines whether telehealth and any prescription are appropriate; payment does not guarantee a prescription. Embody does not practice medicine.

If prescribed, compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Discuss the potential benefits, risks, and alternatives with your clinician.

Patient Obligations

Users agree to provide accurate medical information, follow provider instructions, maintain account confidentiality, and report unauthorized use.

Payment and Subscriptions

Review the price, included services, billing frequency, renewal timing, and cancellation and refund terms presented for your plan before authorizing payment. If a subscription is offered, it may renew according to those disclosed terms until canceled. See our Subscription, Cancellation, and Refund Policy.

Pricing and Availability

Pricing and availability may change. Providers may adjust formulations when appropriate.

Shipping and Delivery

Medication fulfillment requires a valid prescription and pharmacy processing. Availability, shipping methods, delivery estimates, and any shipping charges depend on your prescription, location, and dispensing pharmacy. Contact support for questions about a delayed, lost, or damaged shipment.

Cancellations

Cancellation and refund eligibility depend on the service purchased, the disclosed terms, and the status of clinical and pharmacy work. Contact support to request cancellation or review of a billing concern.

Platform Use

Users may not misuse the platform. Accounts may be suspended or terminated for violations.

Privacy

See our Privacy Policy for information about collection, use, sharing, and your privacy rights. Contact support@bloome.health.

SMS Program

Where text messaging is offered, the enrollment notice explains the messages and applicable consent. Marketing consent is separate from care communications and is not a condition of purchase. Follow the opt-out instructions provided with messages.

Limitation of Liability

Embody is not responsible for medical decisions. Liability is limited to the maximum extent permitted by law.

Indemnification

Users agree to indemnify Embody from claims arising from misuse of services.

Modifications

Terms may be updated at any time. Continued use constitutes acceptance.

Embody
  • 1811 Silverside Road, Suite 260, Wilmington, DE 19180
  • Login

*The assessment made available on the Embody website does not create a doctor-patient relationship between the individual completing the assessment and Embody. Our affiliated network of independent, US-licensed providers, who adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Embody assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and a licensed clinician will meet with an individual after checkout to determine if they qualify for a prescription. Licensed clinicians retain the decision to prescribe compounded GLP-1s to patients.

All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire every 3-4 weeks thereafter. Results may vary and be affected by an individual's adherence to the program and their clinician's recommendations. Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a telehealth consultation and medical history.

We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Embody does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.

Pharmacy Providers
We are partnered with multiple USA certified pharmacies to bring the best product and overall experience to our membership. Our team meets regularly with pharmacies to discuss any product shortages, shipping delays, and get updated reports on their medication testing.

*Results vary based on starting weight and program adherence. Inches lost from hips, waist, chest, thighs and arms in the first month. Patients exercised daily and ate a reduced-calorie diet. Their fat loss is not typical. Results may vary. Medication prescriptions are at the discretion of medical providers and may not be suitable for everyone. Embody patients typically result in 1-2 lbs per week weight loss after 4 weeks, involving a healthy diet and exercise changes. Consult a healthcare professional before using medication or starting any weight loss program. *Based on the average weight loss as reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity.

Medication is included in the cost of the Embody Program. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss. The trademarks, service marks, and trade names (Wegovy®, Ozempic®) displayed on this website are protected and belong to their respective owners. Medical treatment is provided by independent licensed providers. No data, photos, claims or any other information is associated with results derived from clinical trials, studies or public information and is always representative of Embody patient experience.

Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements may be actors or models.

Testimonials on the website are from Embody patients. For patient privacy, images representing those testimonials may use models.

By accepting our Terms of Use, you additionally understand and agree that Embody is not acting as a pharmacy, nor does Embody control or interfere with any such services. By accepting these Terms of Use, you understand and agree that you may be entering into a relationship with a pharmacy, pharmacist, and/or pharmacy group or other such relationship with any one or more such third-party entities. Prescriptions, if issued, are filled by licensed partner pharmacies.

Partner Pharmacies

© 2026 Embody. All rights reserved.

Terms & ConditionsPrivacy PolicyPrivacy PracticesRefund PolicyMedical ConsentFor California ResidentsBill of RightsSafety & Side EffectsTCPA Compliance Policy